Skip to main content

PLEASE NOTE: For everyone’s safety, Fasken recommends anyone on-site at our Canadian offices be familiar with the COVID-19 recommendations in place which may include one or more of the following: social distancing, hand sanitizing, wearing a mask in common areas and proof of full vaccination. These measures apply to lawyers, staff, clients, service providers and other visitors.

Client Work

Foraco closes US$40 million IPO and secondary offering

Fasken
Reading Time 1 minute read Subscribe

Overview

Client

Foraco International SA

On August 2, 2007, Foraco International SA announced that it had successfully completed its initial public offering of 14,040,870 common shares at a price of $2.40 per share for gross proceeds to Foraco of $33,698,088. In conjunction with the completion of the IPO, certain selling shareholders of Foraco sold, pursuant to a secondary offering, an aggregate of 520,000 common shares of Foraco at a price of $2.40 per share for gross proceeds to the selling shareholders of $1,248,000. The IPO and the secondary offering were led by Research Capital Corporation, and included CIBC World Markets Inc. and Canaccord Capital Corporation (collectively, the "Agents"). On August 20, the Agents exercised an over-allotment option in full, raising $5,054,712, resulting in gross proceeds to Foraco from the IPO of approximately $38,752,800. The proceeds will be used by Foraco to retire existing indebtedness, to expand the business by way of strategic acquisitions or through organic growth and for general corporate purposes. Foraco was advised in these offerings in Canada by Georald Ingborg, Lindy Bremner, Josh Lewis, Kate Seniowski and articled student Chris Sharpe of Fasken Martineau.

Team

    Subscribe

    Receive email updates from our team

    Subscribe